SOL S.p.A. logo

SOL S.p.A.

TickerSOL.MIVenueMILSectorBasic MaterialsPrimary listingBeta0.42Avg daily value (30d)$2.9MAvg daily value (3M)$2.8M
€62.70+2.12%
FinScore54

SOL S.p.A. is an Italy-based company in the Basic Materials sector with a market capitalisation of $6.4B. Its FinScore is 54/100; its highest-scoring layer is Momentum (82) and its lowest is Value (25). The shares trade at 32.1x trailing earnings and are up 28% year to date.

Market cap
$6.4B
P/E (TTM)
32.1x
Dividend yield (TTM)
0.73%
ROE
14.9%

Share price performance

Loading chart…

About SOL S.p.A.

www.solgroup.com

SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.

Profile
Sector
Basic Materials
Industry
Chemicals - Specialty
HQ
Italy
Fiscal year-end
December
Trading currency
EUR
Reporting currency
EUR
Fundamentals updated
22 days ago
Market
Market cap
$6.4B
Shares outstanding
90.7M
P/E (TTM)
32.1x
Dividend yield (TTM)
0.73%
Beta (issuer)
0.41
Revenue (latest FY)
€1.8B

FinScore

As of 2026-11-04
Overall54
Quality68
Growth43
Value25
Momentum82
Relative Strength63

Snapshot

Ownership

Closely held
63.0%
Free float
37.0%
Shares outstanding
90.7M

Sign up or log in to see Analysis

Analysis for SOL S.p.A. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for SOL S.p.A. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for SOL S.p.A. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for SOL S.p.A. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for SOL S.p.A. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for SOL S.p.A. is available to Finryse members. The Overview stays open to everyone; creating an account is free.